Merck Announces New Data on Breadth of KEYTRUDA at ASCO: Anti-Tumor Activity Now Shown in 13 Different Tumor Types
June 01, 2015 at 08:03 AM EDT
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the first-time presentation of findings ...
